Skip to content
Raise Lens

This grant has closed. The deadline passed 13 days ago.

You can no longer apply, but the details below are kept for reference, and there are similar open opportunities in the sidebar.

swedish-energy✓ Early-stage friendly

Expression of Interest for IPCEI Projects in Innovative Nuclear Technology – 20 October 2026

In context

This call is open to large companies, small and medium-sized businesses and research institutions and 1 other, at idea and R&D stage, prototype and pilot stage and scale-up and mature. Funding is a grant. Coverage is read from the notice itself: Sweden and the European Union.

Summary

The Swedish Energy Agency is seeking expressions of interest from Swedish companies for direct participation, and from research institutes and universities for associated participation, in the EU-level IPCEI on innovative nuclear technologies. It covers innovative reactors, nuclear fuel and radioisotopes, and the materials and services supply chain, though no funding decision has yet been made.

Summary by Raise Lens from the official notice · 22 Oct 2026Accurate?

About this grant

The Swedish Energy Agency (Energimyndigheten) is inviting expressions of interest from Swedish companies for participation in an Important Project of Common European Interest (IPCEI) on innovative nuclear technologies (IPCEI INT). The Agency has been tasked by the Swedish government with preparing for a possible Swedish participation in this EU-level project. Companies may apply for direct participation, and research institutes and universities may apply for associated participation. The page states there is currently no decision on available funding. The IPCEI aims to contribute to EU-wide goals and strategies, address market failures along the nuclear technology value chain, promote cross-border industrial partnerships, and build investor confidence to attract additional private investment, in order to accelerate deployment of innovative nuclear applications across the EU. The IPCEI is structured around three work streams: Work stream 1 covers innovative reactor technologies, including low-carbon electricity, combined heat and power, radioisotope production, propulsion and off-grid applications, and radioisotope-based power systems. Work stream 2 covers fuel and radioisotopes, including nuclear fuel production, target materials for medical applications, and spent fuel management and value creation. Work stream 3 covers materials, components and services needed to develop, build, operate and decommission nuclear reactors or facilities, and value-chain services for secure supply of radioisotopes. Applicants must submit the company application template and, for direct participation, the IPCEI funding gap template (RDI-FDI). Submissions are made by email and must be in English. An information meeting was held on 28 September via Teams.

Get the official link (free account)

Create a free account to open the official notice and application link: 1 official link a month, free. Pro opens every link.

Eligibility

Direct participation is open to all companies in Sweden that can contribute to the aims of the IPCEI on nuclear technology. Associated participation is open to companies, research institutes and universities in Sweden. Applicants must state whether they seek direct or associated participation.

Key requirements

  • ✓Companies applying for direct participation must submit the company application template and the IPCEI funding gap template (RDI-FDI)
  • ✓Research institutes and universities may apply for associated participation
  • ✓Submissions are made by email and must be in English; no funding decision has been made yet

Funder contact

The notice names a programme contact you can speak to before applying.

Relevant sectors

About this sector

Fusion and nuclear funding backs advanced reactor designs, small modular reactors, fuel cycles, materials and the supply chain behind them. Most of it is public research and milestone-based development money, with strict security and safety requirements. Calls typically favour teams with specialist facilities, licensing knowledge and established research partners.